Cover image of PharmaTalkRadio
(8)
Science

PharmaTalkRadio

Updated 4 days ago

Science
Read more

Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.

Read more

Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.

iTunes Ratings

8 Ratings
Average Ratings
6
2
0
0
0

iTunes Ratings

8 Ratings
Average Ratings
6
2
0
0
0
Cover image of PharmaTalkRadio

PharmaTalkRadio

Updated 4 days ago

Read more

Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.

Rank #1: Immuno-Oncology Drug Development: Challenges & Next Steps

Podcast cover
Read more
PharmaTalk Radio's Valerie Bowling welcomes Immuno-Oncology 360° Co-Chair James Gulley, MD, PhD,National Cancer Institute as he leads a discussion with fellow Co-Chair, Axel Hoos, MD, PhD, GlaxoSmithKline. Together they discuss what's currently happening in Immuno-Oncology and its impact on how cancer is being treated. They cover the latest challenges and next steps. More specifically they also address:
Ipilumumab/Nivo/Pembro challengesWhat can we learn from the development of sipuleucel-T that may be applicable for other therapeutic vaccines?Challenges with the following modalities: Checkpoints, Oncolytic Virus', Adoptive T-Cells, Cancer VaccinesBlinitumumabThe more interesting agents in late stage development now in immunotherapy and its promiseImmune related adverse eventsAdoptive cellular therapies, what is the most promising?Will IO become backbone therapies for cancer?What's the next set of assets that are going to come out?Promises in combination therapies?What can we expect next?
Guests:

James Gulley, MD, PhD
Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute

Axel Hoos, MD, PhD, VP, Oncology R&D,GlaxoSmithKline

The Immuno-Oncology360° conference is scheduled for February 2-3, 2016  at the New York Academy of Medicine in NYC. For more information, please visit www.theconferenceforum.org.
Dec 21 2015
58 mins
Play

Rank #2: Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark

Podcast cover
Read more
During his graduate work, Dr Benjamine Liu observed the many bottlenecks that get in the way of clinical trials slowing the development of new treatments for patients. This challenge inspired him to launch Trialspark.

Trialspark partners with doctors to create FDA compliant trial sites within their existing practices (like Airbnb), unlocking the 98% of patients and doctors not involved in trials today and democratizing access to research treatments.  In this podcast discussion with Ben, we discuss how to reimagine clinical trials, entrepreneurism, the rise of Trialspark and reducing the barriers for patients and investigators. 

Ben will be speaking at DPharm on September 26th in Boston with Dr Ulo Palm, SVP Global Drug Development Operations, Allergan on a case study to scale more efficient clinical trials.

For more information about Trialspark, visit www.trialspark.com

For more information about DPharm visit www.theconferenceforum.org

Producer: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm
Aug 17 2018
22 mins
Play

Rank #3: Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design

Podcast cover
Read more
Roughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research studies so far have a poor record. Patients can face incredible enrollment hurdles in clinical trials. 

A Patient Registry can be very useful in identifying patients. A registry can also address the original problem statement about failed trials. A robust, living registry becomes a data pool from which we can improve both drug discovery, using probabilistic statistics and AI/ML to identify new drug candidates, and drug development, using simulators to predict likelihood of success in Phase 2 or 3.

In this podcast, we discuss major challenges facing developers of Alzheimer’s therapies and address patient registries and how they can improve enrollment and trial design. In this podcast, we will hear some details about the HealthyMindsRegistry, Synexushmr.com and the Protect Study Registry, Protectstudy.org.uk registry. For US and UK citizens over 50 who have not been diagnosed with dementia can participate in the registry on-line.

Guests:

Dr Clive Ballard, Pro-Vice Chancellor and Executive Dean, University of Exeter, External partner in the AES HealthyMinds Registry (HMR)

Dr Heather Bryson, Director, Operational and Strategic Solutions at Accelerated Enrollment Solutions, (AES) 

Host: Dr Julie Adams, Psychiatrist and Regional Medical Officer, PPD Biotech

Producer: Valerie Bowling, Executive Director, the Conference Forum
Jun 25 2019
30 mins
Play

Rank #4: Fireside Chat: Lessons Learned from a Drug Delivery Pioneer and Risk-Taker

Podcast cover
Read more
John Patton, PhD, Chief Executive Officer and Chairman with Dance Biopharma and Ann Daugherty, PhD, Senior Manager, Drug Delivery with Genentech present the closing talk at Drug Delivery West, held May 21-22, 2018 in San Francisco.  In this talk they discuss the lessons learned from drug delivery, what to be aware of in the future, and how to improve drug delivery methods.  The next conference in Drug Delivery is the 8th annual PODD: Partnership Opportunities in Drug Delivery on October 17-18, 2018 in Boston. For more information, visit www.theconferenceforum.org
Jun 21 2018
40 mins
Play

Rank #5: Key Trends in Drug Delivery: Expert Perspective

Podcast cover
Read more
Opening talk at Drug Delivery West, 2018

Key Trends in Drug Delivery: Expert Perspective

Randall Mrsny, PhD

Professor's Chair, Department of Pharmacy and Pharmacology,

University of Bath
Jun 23 2018
34 mins
Play

Rank #6: How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage

Podcast cover
Read more
Dr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked the audience through some examples of the engagement initiatives supported by:

• Creation of a framework and toolkit that builds on existing infrastructure

• Networks of champions and project leads

• Project planning

• Emerging best practices being shared throughout the organization
Dr Metcalf will also be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where she leads a panel with patients and advocacy on Mapping Out the Patient Decision Making Journey. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. For more information visit www.theconferenceforum.org.
Jan 14 2019
15 mins
Play

Rank #7: Managing the Role of Chief Medical Officer in a Biotech

Podcast cover
Read more
The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.  
From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO & Founder of Great Plains Biotechnology, to discuss the role of the CMO and how to best manage it. 
Topics include: 
What should a CMO be focused on? Functioning with restrictive capital Supporting a CEO who does not have experience in the therapeutic area you are in charge of The great balancing act
Sep 06 2013
59 mins
Play

Rank #8: How Tesaro is Integrating the Patient in the Clinical Development Process

Podcast cover
Read more
In this talk from the 5th annual Patients as Partners US conference, Beth Zaharoff, Director, Patient-Focused Clinical Trial Engagement of Tesaro will walk the audience through how they integrated patient input throughout multiple stages of the development process.

Other discussion points include:
How Tesaro is working to eliminate some of the burdens inherent in clinical trial participationWhat patient focus means to Tesaro and why/how they decided to jump in the deep endTesaro focus groups and what they learned from the experts
Join us this year at the 6th annual Patients as Partners US conference, taking place March 11-12, 2019 in Philadelphia.
Dec 12 2018
26 mins
Play

Rank #9: What are the Regulatory and Ethical Concerns of Integrating Care and Research?

Podcast cover
Read more
In this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in the integration of clinical care and clinical research. More specifically:
Research and care or treatment are separate spheres in the regulatory and ethical worlds. What happens when they are brought together?Are there ethical barriers that need to be overcome to allow clinical research to be offered as an option as part of clinical care?What are the ethical issues that surround offering a patient the opportunity to consider enrolling in a clinical trial?What current efforts are underway to address these issues?
This session was presented at the Clinical Research as a Care Option (CRAACO) meeting in April 2018 in Cambridge, MA.

The 2019 CRAACO conference will take place April 29-30, 2019 in Raleigh-Durham, NA. Learn more here.
Feb 06 2019
35 mins
Play

Rank #10: Patient Perspectives on Drug Delivery Needs Present and Future

Podcast cover
Read more
This panel, presented at the inaugural Drug Delivery West conference in 2018, provides patient perspectives on what they want from drug delivery technologies. These case examples provide insight that every technology can benefit from and lessons learned through our patient representatives.

Co-Moderators:

Valerie Bowling, Patient Advocate and Executive Director, Drug Delivery West

Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen

Panelists:

Cynthia Goldstein, Patient & Communications Specialist

Mikaela Saugstad, Patient, Co-Founder, Director of Customer Relations & Marketing, Gigil Precision LLC

Lily Stairs, Patient and Head of Patient Advocacy, Clara Health
To learn more about the 2019 Drug Delivery West conference taking place May 6-7, 2019 in San Francisco, CA, please click here.
Feb 25 2019
42 mins
Play

Rank #11: Next Generation of Combination Immunotherapy with Dr Patrick Hwu of MD Anderson

Podcast cover
Read more
At 2016's Rational Combinations 360° meeting, Dr Patrick Hwu of MD Anderson Cancer Center delivered a keynote address on the future outlook behind combination immunotherapy. Dr Hwu addresses innovations behind combination therapy, specifically focusing on what’s next after checkpoint combinations and whether combination of adoptive T-cell therapy and anti-checkpoint inhibitor therapies are the next wave.

Dr Hwu serves as a lead advisor for the 2nd annual Rational Combinations 360° meeting, which takes place June 28-29, 2017, at the The New York Academy of Medicine. Preview the program agenda, including Dr Hwu's plenary session on "DE-RISKING OF COMBINATION IMMUNOTHERAPIES."
Jun 07 2017
33 mins
Play

Rank #12: 5 Minute Overview of DPharm (Disrupting Clinical Trials) Europe: What to Expect?

Podcast cover
Read more
The 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event is led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can’t Wait).  This radio blogcast gives a five minute overview of the event, which presents global case studies on:
Real World Clinical Trial Strategies and ResultsNew Leadership in Driving Clinical Trial InnovationStrategies to Validate the Siteless TrialCommunity Outreach and Education in Clinical TrialsNew Financial ModelsPatient Involvement and EngagementBrexit Update and Potential Impact on R&DProtocol SimulationAdaptive Trial Model 
DPharm EU takes place at the Millennium Hotel in London on February 8-9, 2017. For more information, visit www.theconferenceforum.org
Jan 26 2017
6 mins
Play

Rank #13: How Digital Biomarker Innovation is Modernizing Clinical Endpoints

Podcast cover
Read more
In this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease and Multiple Sclerosis. Session takeaways include:
Understand what Digital Biomarker innovation means for the future of clinical development and potentially personalized healthcare.Be inspired to use mobile sensors technology in the context of clinical trials and beyond.Develop a detailed understanding of the underlying complexity to run such efforts and be able to plan for it.Understand how regulators are looking at these novel approaches.
Speaker:

Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)

The 9th annual DPharm conference with take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.
Jul 31 2019
17 mins
Play

Rank #14: Immuno-Oncology 360°: Business Models for Complex Science by Dr Axel Hoos of GSK

Podcast cover
Read more
Originally presented during the business aspects plenary session at Immuno-Oncology 360° 2017, Dr Axel Hoos of GSK discusses business models for complex science. 

Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City. Dr Hoos returns as lead advisor, as well as moderating a talk called, "Investor Roundtable: The Role of IO within Large Pharma - Where Does it Stand?" with panelists from Citi, Atlas Venture, New Enterprise Associates, and SR One Ltd.
Jun 21 2017
25 mins
Play

Rank #15: PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes

Podcast cover
Read more
In this podcast, Valerie Bowling, Director of PODD, walks you through what to expect at PODD 2019 in under 4 minutes. The 9th annual PODD conference features the following:
Building a Company around a Transformative Drug Delivery Invention with MIT's Dr Robert Langer, Dr Sangeeta Bhati, Dr Giovanni Traverso and Harvard Medical School's Dr Jeffrey Karp.Modality Fluid Development: Tales of Evolving Pipelines and Drug Delivery Solutions with Merck's, VP, Pharmaceutical Sciences, Dr Allen TempletonGene Therapy Keynote with Spark Therapeutics, President and Head of R&D, Dr Katherine HighZeitgeist Presentation on Immune Targeting Nanomedicine by AstraZeneca’s, VP, External Innovation and Novel Product Technologies, Dr Anand SubramonyConference Chair opening remarks provided by AstraZeneca's, Dr Shawn Davis
Additional Featured Speakers:
Roche’s, Senior Portfolio Strategy Director, Dr Beate Bittner will moderate the Formulation & Device Lifecycle Management for Biotherapeutics – Clinical and Industry Perspectives on Subcutaneous Delivery panel.Drug Delivery Pipeline and Technologies, A Year in Review, with Pharmacircle’s, VP, Kurt SedoDelivering Flexible Dosage Forms with Pfizer's Dr Advait Badkar
The 9th annual PODD conference will take place on October 7-8, 2019 in Boston, MA. Learn more at theconferenceforum.org
Aug 20 2019
5 mins
Play

Rank #16: Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting

Podcast cover
Read more
In this podcast from the 2018 Mobile in Clinical Trials conference, Eli Lilly's Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, reported on incorporating a variety of mobile devices – including a smart phone, smart insulin pens, connected devices, mifi, and laptops, into a clinical trial.

Considerations and lessons learned for:

• Connecting all the devices

• Implementation differences between traditional vs siteless

• Coordinating the equipment; challenges and successes

• Lessons learned

• What’s next?

Speaker: Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, Eli Lilly & Co
Aug 15 2019
28 mins
Play

Rank #17: Keytruda in Combo with Chemo in NSCLC

Podcast cover
Read more
Originally recorded at the 4th annual Immuno-Oncology 360° 2018 event, Dr Corey Langer, Director, Thoracic Oncology and Professor of Medicine for the Perelman Center for Advanced Medicine at the University of Pennsylvania, discusses data on Keytruda in combination with chemotherapy in non-small cell lung cancer.

This year, the University of Pennsylvania will be represented by Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies. Dr Ruella will be discussing the next steps for CAR-T therapy for cancer on day three during the Next Generation Cell Therapy Plenary

To join in on the discussion at the 5th annual IO360 conference taking place February 6-8, 2019 in New York, NY!
Dec 11 2018
25 mins
Play

Rank #18: CAR-T Therapy: Optimization Through Engineering T-cells or Combinations

Podcast cover
Read more
Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania focuses on the next steps for CAR-T therapy for cancer, discussing the novel approaches that are being developing in Dr Carl June’s lab including CAR-T combinations with small molecules and gene-editing.

Save the date for IO Combinations 360° happening June 20-21, 2019 at the Wyndham Historic District Hotel, Philadelphia, PA and for IO360° happening February 26-28, 2020 at the Crowne Plaza Times Square in New York City.
May 02 2019
20 mins
Play

Rank #19: Entrepreneur Data Scientist, Ben Liu on Solving Bottlenecks in Clinical Research

Podcast cover
Read more
Trialspark, CEO, Dr Ben Liu recently sat down with Valerie Bowling, Executive Director of DPharm in a podcast discussion.  Valerie checked in with Ben on the progress of life as a data science entrepreneur. They also discussed how Ben and his team are solving big challenges in drug development, new evolving R&D models and more. On Sept 17th, Ben will be interviewing Pfizer's Rod Mackenzie, Chief Development Officer at DPharm: Disruptive Innovations to Advance Clinical Trials in Boston. For more information, please visit theconferenceforum.org
Jul 23 2019
19 mins
Play

Rank #20: Addressing R&D Challenges using Drug Delivery Technologies

Podcast cover
Read more
The expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will address a specific disease area and discuss the role of drug delivery in the treatment of disease. The panel will also cover currently available delivery technologies and where improvement is needed.

Moderator: Ann Daugherty, PhD

Senior Manager, Drug Delivery, Genentech

Panelists: Marianne Ashford, PhD

Senior Principal Scientist, Pharmaceutical Sciences, AstraZeneca

Advait Badkar, PhD

Senior Director Novel Delivery Technologies, Bio Therapeutics, Pfizer

Marian Gindy, PhD

Executive Director Pharmaceutical Sciences, Merck

Kapil Gupta, PhD

Associate Director, Protein Pharmaceutical Development, Biogen

Evan Thackaberry, PhD, DABT

Headm Preclinical Development, Ra Pharmaceuticals

This talk was given on Day 2 of the Partnership Opportunities in Drug Delivery (PODD) 2017 Meeting.
Jun 05 2018
45 mins
Play

Similar Podcasts